Wang Rui, Tang Qianzi
Institute of Animal Genetics and Breeding, College of Animal Science and Technology, Sichuan Agricultural University, Chengdu 611130, China.
Int J Mol Sci. 2021 May 26;22(11):5640. doi: 10.3390/ijms22115640.
Enhancers are critical genomic elements that can cooperate with promoters to regulate gene transcription in both normal and cancer cells. Recent studies reveal that enhancer regions are transcribed to produce a class of noncoding RNAs referred to as enhancer RNAs (eRNAs). Emerging evidence shows that eRNAs play important roles in enhancer activation and enhancer-driven gene regulation, and the expression of eRNAs may be a critical factor in tumorigenesis. The important roles of eRNAs in cancer signaling pathways are also gradually unveiled, providing a new insight into cancer therapy. Here, we review the roles of eRNAs in regulating cancer signaling pathways and discuss the potential of eRNA-targeted therapy for human cancers.
增强子是关键的基因组元件,可与启动子协同作用,在正常细胞和癌细胞中调节基因转录。最近的研究表明,增强子区域会转录产生一类非编码RNA,称为增强子RNA(eRNA)。新出现的证据表明,eRNA在增强子激活和增强子驱动的基因调控中发挥重要作用,并且eRNA的表达可能是肿瘤发生的关键因素。eRNA在癌症信号通路中的重要作用也逐渐被揭示,为癌症治疗提供了新的见解。在此,我们综述了eRNA在调节癌症信号通路中的作用,并讨论了针对eRNA的疗法在人类癌症治疗中的潜力。